Vanguard Group
CRL icon

Vanguard Group’s Charles River Laboratories CRL Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$882M Sell
5,811,754
-293,724
-5% -$44.6M 0.01% 738
2025
Q1
$919M Sell
6,105,478
-53,448
-0.9% -$8.04M 0.02% 681
2024
Q4
$1.14B Buy
6,158,926
+60,497
+1% +$11.2M 0.02% 618
2024
Q3
$1.2B Sell
6,098,429
-5,020
-0.1% -$989K 0.02% 599
2024
Q2
$1.26B Buy
6,103,449
+56,982
+0.9% +$11.8M 0.02% 568
2024
Q1
$1.64B Buy
6,046,467
+66,161
+1% +$17.9M 0.03% 508
2023
Q4
$1.41B Buy
5,980,306
+26,446
+0.4% +$6.25M 0.03% 527
2023
Q3
$1.17B Buy
5,953,860
+29,482
+0.5% +$5.78M 0.03% 546
2023
Q2
$1.25B Sell
5,924,378
-91,343
-2% -$19.2M 0.03% 537
2023
Q1
$1.21B Buy
6,015,721
+58,761
+1% +$11.9M 0.03% 535
2022
Q4
$1.3B Sell
5,956,960
-20,159
-0.3% -$4.39M 0.04% 498
2022
Q3
$1.18B Buy
5,977,119
+7,087
+0.1% +$1.39M 0.03% 507
2022
Q2
$1.28B Buy
5,970,032
+34,305
+0.6% +$7.34M 0.04% 501
2022
Q1
$1.69B Buy
5,935,727
+66,602
+1% +$18.9M 0.04% 487
2021
Q4
$2.21B Sell
5,869,125
-52,925
-0.9% -$19.9M 0.05% 407
2021
Q3
$2.44B Buy
5,922,050
+10,416
+0.2% +$4.3M 0.06% 342
2021
Q2
$2.19B Buy
5,911,634
+754,558
+15% +$279M 0.05% 387
2021
Q1
$1.49B Buy
5,157,076
+129,172
+3% +$37.4M 0.04% 491
2020
Q4
$1.26B Buy
5,027,904
+110,317
+2% +$27.6M 0.04% 505
2020
Q3
$1.11B Sell
4,917,587
-209,018
-4% -$47.3M 0.04% 491
2020
Q2
$894M Sell
5,126,605
-235,189
-4% -$41M 0.03% 536
2020
Q1
$677M Buy
5,361,794
+42,418
+0.8% +$5.35M 0.03% 558
2019
Q4
$813M Buy
5,319,376
+43,830
+0.8% +$6.7M 0.03% 616
2019
Q3
$698M Buy
5,275,546
+85,424
+2% +$11.3M 0.03% 645
2019
Q2
$736M Sell
5,190,122
-28,461
-0.5% -$4.04M 0.03% 634
2019
Q1
$758M Sell
5,218,583
-64,256
-1% -$9.33M 0.03% 595
2018
Q4
$598M Buy
5,282,839
+68,398
+1% +$7.74M 0.03% 630
2018
Q3
$702M Sell
5,214,441
-32,250
-0.6% -$4.34M 0.03% 641
2018
Q2
$589M Buy
5,246,691
+161,284
+3% +$18.1M 0.02% 689
2018
Q1
$543M Buy
5,085,407
+29,537
+0.6% +$3.15M 0.02% 717
2017
Q4
$553M Buy
5,055,870
+62,728
+1% +$6.87M 0.02% 706
2017
Q3
$539M Sell
4,993,142
-67,588
-1% -$7.3M 0.03% 687
2017
Q2
$512M Buy
5,060,730
+27,217
+0.5% +$2.75M 0.03% 693
2017
Q1
$453M Buy
5,033,513
+225,563
+5% +$20.3M 0.02% 753
2016
Q4
$366M Buy
4,807,950
+204,507
+4% +$15.6M 0.02% 803
2016
Q3
$384M Buy
4,603,443
+89,674
+2% +$7.47M 0.02% 744
2016
Q2
$372M Buy
4,513,769
+157,711
+4% +$13M 0.02% 723
2016
Q1
$331M Buy
4,356,058
+173,314
+4% +$13.2M 0.02% 752
2015
Q4
$336M Buy
4,182,744
+97,314
+2% +$7.82M 0.02% 740
2015
Q3
$260M Buy
4,085,430
+71,262
+2% +$4.53M 0.02% 840
2015
Q2
$282M Buy
4,014,168
+69,798
+2% +$4.91M 0.02% 860
2015
Q1
$313M Buy
3,944,370
+64,694
+2% +$5.13M 0.02% 791
2014
Q4
$247M Buy
3,879,676
+9,712
+0.3% +$618K 0.02% 855
2014
Q3
$231M Sell
3,869,964
-19,332
-0.5% -$1.15M 0.02% 853
2014
Q2
$208M Buy
3,889,296
+323,447
+9% +$17.3M 0.02% 937
2014
Q1
$215M Buy
3,565,849
+250,685
+8% +$15.1M 0.02% 893
2013
Q4
$176M Buy
3,315,164
+107,313
+3% +$5.69M 0.02% 969
2013
Q3
$148M Buy
3,207,851
+122,499
+4% +$5.67M 0.01% 995
2013
Q2
$127M Buy
+3,085,352
New +$127M 0.01% 1014